Quantum Biopharma (QNTM) Change in Cash (2019 - 2026)

Quantum Biopharma (QNTM) has 7 years of Change in Cash data on file, last reported at $2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 198.34% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $823595.0 (down 62.36% YoY), and the FY2025 full-year result was -$4.1 million, down 226.3% from the prior year.
• Change in Cash improved to $2.4 million in Q1 2026, from -$4.5 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $7.9 million in Q3 2022 to a low of -$29.8 million in Q4 2022.
• A 4-year average of -$1.3 million and a median of $118606.0 in 2024 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash plunged 3924.81% in 2025 and soared 198.34% in 2026, its largest moves.
• Tracing QNTM's Change in Cash over 4 years: stood at -$29.8 million in 2022, then soared by 100.4% to $118606.0 in 2024, then sank by 3924.81% to -$4.5 million in 2025, then soared by 153.71% to $2.4 million in 2026.
• Business Quant data shows QNTM's Change in Cash at $2.4 million in Q1 2026, -$4.5 million in Q4 2025, and $4.9 million in Q3 2025.